Domingo resigns as food and drug regulator chief | ABS-CBN
ADVERTISEMENT

Welcome, Kapamilya! We use cookies to improve your browsing experience. Continuing to use this site means you agree to our use of cookies. Tell me more!
Domingo resigns as food and drug regulator chief
Domingo resigns as food and drug regulator chief
Gillan Ropero,
ABS-CBN News
Published Jan 03, 2022 05:18 PM PHT

MANILA - Health Undersecretary Eric Domingo said Monday he has resigned as director-general of the Food and Drug Administration.
MANILA - Health Undersecretary Eric Domingo said Monday he has resigned as director-general of the Food and Drug Administration.
Domingo was named as officer-in-charge of the regulatory office in May 2019, according to the DOH. He was named as FDA director-general in May 2020.
Domingo was named as officer-in-charge of the regulatory office in May 2019, according to the DOH. He was named as FDA director-general in May 2020.
"Yes, effective today. I believe I did my part to help during the pandemic. The FDA is now stronger, more efficient and systems are in place. It's time for me to move on to other things," he told ABS-CBN News.
"Yes, effective today. I believe I did my part to help during the pandemic. The FDA is now stronger, more efficient and systems are in place. It's time for me to move on to other things," he told ABS-CBN News.
It was under Domingo's helm that the FDA granted the emergency use authorization of nine COVID-19 vaccines and two drugs used in coronavirus treatment.
It was under Domingo's helm that the FDA granted the emergency use authorization of nine COVID-19 vaccines and two drugs used in coronavirus treatment.
ADVERTISEMENT
FDA deputy director general Oscar Guiterrez will be assigned as officer-in-charge of the regulator, the Department of Health said.
FDA deputy director general Oscar Guiterrez will be assigned as officer-in-charge of the regulator, the Department of Health said.
More details to follow.
RELATED VIDEO
RELATED VIDEO
Read More:
Eric Domingo
Food and Drug Administration
FDA
DOH
Department of Health
Philippines COVID-19
coronavirus
ADVERTISEMENT
ADVERTISEMENT